CARIBOU BIOSCIENCES I
2.7800
07-November-24 14:59:58
15 minutes delayed
Stocks
+0.0300
+1.09%
Today's range
2.3700 - 2.9995
ISIN
N/A
Source
NASDAQ
-
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
06 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
25 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
03 Sep 2024 07:01:11 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
26 Aug 2024 15:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
12 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
06 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
09 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
30 May 2024 15:01:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
07 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
01 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
04 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 15:30:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
15 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
07 Jan 2024 10:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 15:02:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
07 Nov 2023 15:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >